Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
Beta-Blockers Emerge as Beneficial in Early and Triple-Negative Breast Cancer: Reasons Why and the Role of a Sympathetic Overdrive in TNBC Patients
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Encouraging Results from Phase 2a COVID-19 Clinical Trial with the Oral Direct-Acting Antiviral MolnupiravirJuly 7, 2021
Platelet-activating anti-PF4 antibodies linked to the vaccine-induced immune thrombotic thrombocytopeniaApril 19, 2021
Identification of GM-SCF as possible distinctive blood marker predicting severe COVID-19March 23, 2021
Bamlanivimab (an Investigational Monoclonal Antibody): FDA Authorizes its Emergency Use for the Treatment of Mild to Moderate COVID-19November 11, 2020
High Affinity Human Antibody Component Identified as a Potential Targeted SARS-Cov-2 TherapyNovember 3, 2020
NIH begins the first large randomized controlled trial of the combination of interferon beta-1a and remdesivir for treating COVID-19August 13, 2020
